Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Ann Plast Surg ; 72(1): 94-9, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23403542

RESUMEN

BACKGROUND: A lot of methods have been intensively investigated to improve random skin flap survival. Decreasing inflammation and alleviating tissue injury have been reported to be effective in improving survival ratio. Vasonatrin peptide (VNP) is a chimera of atrial natriuretic peptide (ANP) and C-type natriuretic peptide (CNP). The current study demonstrates that VNP possesses the venodilating actions of CNP, the natriuretic actions of ANP, and the unique arterial vasodilating actions not associated with either ANP or CNP. However, its effects on skin flap survival have not been previously reported. METHODS: Sprague-Dawley rats, weighing 220 to 260 g, were randomly divided into 2 groups, namely, the VNP-treated group and the control group. Rectangular random dorsal skin flaps measuring 3 × 9 cm including the panniculus carnosus were elevated, then the flaps were sutured into their original places. In the VNP group, 0.1 mg/kg of VNP was administered intravenously (IV) after surgery and then daily for 3 days. In the control group, 1 mL/kg of saline was administered IV after surgery and then daily for 3 days. To observe the effects of VNP, blood perfusion, histopathological examination, the inflammatory mediators (tumor necrosis factor α, interleukin 1ß, and interferon γ), and biochemical analysis (malondialdehyde, glutathione, and myeloperoxidase) were detected and the flap viability was evaluated 7 days after surgery by measuring necrotic flap area and total flap area. RESULTS: The viability measurements showed the percentage of flap survival was increased in the VNP-treated group (76.53% ± 6.36%) as compared with the control group (61.12% ± 4.92%) (P < 0.05), and the histological and biochemical assays corroborated the data. The blood perfusion of flaps in the VNP-treated group was higher than the control group (P < 0.05). The inflammatory mediators (tumor necrosis factor α, interleukin 1ß, and interferon γ) were significantly lower in the VNP-treated group than the control group (P < 0.05). CONCLUSIONS: This study found that VNP, which could elevate the tissue blood perfusion and mitigate the tissue damage and inflammatory reaction, is associated with a higher percentage of survival random pattern skin flap area.


Asunto(s)
Factor Natriurético Atrial/farmacología , Supervivencia de Injerto/efectos de los fármacos , Natriuréticos/farmacología , Piel/efectos de los fármacos , Colgajos Quirúrgicos/irrigación sanguínea , Vasodilatadores/farmacología , Administración Intravenosa , Animales , Factor Natriurético Atrial/uso terapéutico , Biomarcadores/metabolismo , Esquema de Medicación , Supervivencia de Injerto/fisiología , Inmunohistoquímica , Flujometría por Láser-Doppler , Natriuréticos/uso terapéutico , Necrosis/etiología , Necrosis/metabolismo , Necrosis/patología , Necrosis/prevención & control , Complicaciones Posoperatorias/metabolismo , Complicaciones Posoperatorias/patología , Complicaciones Posoperatorias/prevención & control , Distribución Aleatoria , Ratas , Ratas Sprague-Dawley , Piel/irrigación sanguínea , Piel/metabolismo , Piel/patología , Colgajos Quirúrgicos/patología , Colgajos Quirúrgicos/fisiología , Vasodilatadores/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA